financetom
Business
financetom
/
Business
/
Billion-Dollar Cannabis Company Closes Acquisition Of Three US Breweries, What's Next For Tilray
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Billion-Dollar Cannabis Company Closes Acquisition Of Three US Breweries, What's Next For Tilray
Sep 3, 2024 8:53 AM

Tilray Brands, Inc ( TLRY ). announced on Tuesday that it has completed the previously announced acquisition of craft breweries Hop Valley Brewing Company,Terrapin Beer Co., and Revolver Brewing, from Molson Coors Beverage Company ( TAP/A ) .

Why It Matters

The acquisition bolsters Tilray’s leadership position in the U.S. craft beer market as the 5th largest craft brewer in the country and the top craft brewer in the Pacific Northwest and Georgia. Tilray is based in Canada.

This also strengthens the company's presence in Texas – the second largest beer consumption state – and expands Tilray's craft beer portfolio across key beer markets, adding 30% new beer-buying accounts.

“Tilray Brands is crafting a new future for brands in the craft beer industry,” said Irwin D. Simon, chairman and CEO of Tilray Brands ( TLRY ). "This strategic acquisition creates additional growth opportunities for our global beverage business, which reinforces our commitment to enhancing shareholder value."

Known for brands like SweetWater Brewing and Montauk Brewing Company, Tilray earlier said it expects a 30% growth in its beer business from this acquisition.

Read Also: ‘Tilray Should Be A Long-Term Holding In Any Global Portfolio Of Cannabis Stocks,' Says Analyst

Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.

What's Next

"Our plan is to drive growth and maximize the potential of these brands to their fullest capacity, while maintaining our dedication to delivering high-quality products and meeting the evolving needs of our consumers," Simon added.

For Tilray, this acquisition is set to increase their beer production to 15 million cases annually. Ty Gilmore, president of Tilray Beverages in North America said he was looking forward to bringing new team members and distributors on board.

According to Michelle St. Jacques, the company's chief commercial officer, with the move Molson Coors ( TAP/A ) seeks to redefine its business strategy with this deal. "This deal lets us focus our efforts on projects that will significantly grow our top-tier U.S. beer and other beverage lines."

Read Next:

Is Tilray Really Worth $2B? Analysts Sees Path To $10B Market Opportunity

TLRY Price Action

Tilray's shares traded 1.4620% lower at $1.685 per share at the time of writing on Tuesday morning.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Infinera Swings to Preliminary Q1 Non-GAAP Loss, Revenue Falls; Issues Q2 Outlook -- Shares Fall After Hours
Infinera Swings to Preliminary Q1 Non-GAAP Loss, Revenue Falls; Issues Q2 Outlook -- Shares Fall After Hours
May 14, 2024
04:38 PM EDT, 05/14/2024 (MT Newswires) -- Infinera ( INFN ) reported a Q1 preliminary non-GAAP loss late Tuesday of $0.17 per diluted share, compared with earnings of $0.02 per share a year earlier. Analysts polled by Capital IQ expected a loss of $0.13. Preliminary revenue for the quarter ended March 30 was $306.9 million, down from $392.1 million a...
United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing
May 14, 2024
04:39 PM EDT, 05/14/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on May 10, 2024, sold 7,200 shares in United Therapeutics ( UTHR ) for $1,911,532. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 130 shares of the company, with 130 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000141588924013129/xslF345X03/form4-05142024_040509.xml ...
Lifestance Health Group Insider Sold Shares Worth $362,567, According to a Recent SEC Filing
Lifestance Health Group Insider Sold Shares Worth $362,567, According to a Recent SEC Filing
May 14, 2024
04:40 PM EDT, 05/14/2024 (MT Newswires) -- Paula Cipollone, Chief Business Transformation Officer, on May 10, 2024, sold 50,278 shares in Lifestance Health Group ( LFST ) for $362,567. Following the Form 4 filing with the SEC, Cipollone has control over a total of 239,915 shares of the company, with 239,915 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1845257/000095017024059636/xslF345X03/ownership.xml ...
Nu Holdings Q1 Earnings, Revenue Increase -- Shares Decline
Nu Holdings Q1 Earnings, Revenue Increase -- Shares Decline
May 14, 2024
04:38 PM EDT, 05/14/2024 (MT Newswires) -- Nu Holdings ( NU ) reported Q1 earnings Tuesday of $0.08 per diluted share, up from $0.03 a year earlier. Analysts polled by Capital IQ expected $0.07. Revenue for the quarter ended March 31 was $2.74 billion, up from $1.62 billion a year earlier. Analysts surveyed by Capital IQ expected $2.53 billion. Shares...
Copyright 2023-2026 - www.financetom.com All Rights Reserved